Any research that provides additional insight into Alzheimer’s is critical to finding a cure. It is also important for patients and families affected by diseases such as Alzheimer’s to consider participating in clinical studies. One such study is the ICARA (Bapi) Study (www.icarastudy.com), whose goal is to explore if an investigational drug, called Bapineuzumab, can help slow the progression of Alzheimer’s Disease. Clinical studies that test new treatments are the best chance we have for fighting this disease. Current therapies for Alzheimer’s treat the symptoms associated with it, not the disease itself.
U.S. News's "Best" delivers recognized, authoritative information and clear, objective rankings that help readers plan for their life and ultimately, make the most of it.
Reader Comments
Back to article
Laura_ICARAstudy of IL 7:49PM September 08, 2009